Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: The SELECT-1 randomized clinical trial

1. Jänne, P.A.
2. Van Den Heuvel, M.M.
3. Barlesi, F.
4. Cobo, M.
5. Mazieres, J.
6. Crinò, L.
7. Orlov, S.
8. Blackhall, F.
9. Wolf, J.
10. Garrido, P.
11. Poltoratskiy, A.
12. Mariani, G.
13. Ghiorghiu, D.
14. Kilgour, E.
15. Smith, P.
16. Kohlmann, A.
17. Carlile, D.J.
18. Lawrence, D.
19. Bowen, K.
20. Vansteenkiste, J.